Showing results (51-60 of 92) with videos related to
Sort By:
Pageof 10
Mutation Research|July 1, 1987
Effect of histamine H2-receptor antagonist therapy on the mutagenic activity of gastric juiceH J O'Connor, S E Riley, A T Axon, et al.Journal of Immunological Methods|August 12, 1983
Improved conditions for the production of monoclonal antibodies to carcinogen-modified DNA, for use in enzyme-linked immunosorbent assays (ELISA)P J Hertzog, A Shaw, J R Lindsay Smith, et al.Mutation Research|October 1, 1993
Immunoaffinity concentration of human lung DNA adducts using an anti-benzo[a]pyrene-diol-epoxide-DNA antibody. Analysis by 32P-postlabelling or ELISAM M King, J Cuzick, D Jenkins, et al.Carcinogenesis|May 1, 1985
Studies on the detoxication of microsomally-activated aflatoxin B1 by glutathione and glutathione transferases in vitroB Coles, D J Meyer, B Ketterer, et al.Mutation Research|December 13, 2000
Analysis of DNA adducts by accelerator mass spectrometry in human breast tissue after administration of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and benzo[a]pyreneT J Lightfoot, J M Coxhead, B C Cupid, et al.Nature|December 22, 1988
Correlation of DNA adduct levels in human lung with cigarette smokingD H Phillips, A Hewer, C N Martin, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 1996
Molecular screening of multifocal transitional cell carcinoma of the bladder using p53 mutations as biomarkersX Xu, M J Stower, I N Reid, et al.Journal of Pharmaceutical Sciences|January 10, 2002
Comparison of the absorption of micronized (Daflon 500 mg) and nonmicronized 14C-diosmin tablets after oral administration to healthy volunteers by accelerator mass spectrometry and liquid scintillation countingR C Garner, J V Garner, S Gregory, et al.Mutation Research|August 1, 1995
Cyclophosphamide: review of its mutagenicity for an assessment of potential germ cell risksD Anderson, J B Bishop, R C Garner, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 1, 1997
A hot spot for p53 mutation in transitional cell carcinoma of the bladder: clues to the etiology of bladder cancerX Xu, M J Stower, I N Reid, et al.Pageof 10